Vice President, Business Development and Chief Operating Officer, Signpath Pharma, Inc; formerly (1) Associate General Counsel, Sun Products Corporation; and (2) General Counsel, Napro Biotherapeutics Inc
As General Counsel of a pharmaceutical company, I was a client of Malcolm’s for over a decade. During that time, Malcolm and his firm assisted my company in various patent-related endeavours in Europe. They were responsible for prosecution of an extensive patent portfolio of complex pharmaceutical patents and Malcolm also represented us in litigation before the European Patent Office, and assisted in litigation in the U.K. courts.
Through this long association, I came to know Malcolm’s competencies very well. He is an exceptional lawyer. He provided sound guidance on patent matters and is an able advocate, representing my company interests very effectively in adversarial proceedings before the EPO. He had an excellent grasp of our strategic position and provided valuable advice regarding the interplay between our patent portfolio and business interests
I was also uniformly impressed by the attention to detail, legal and technical knowledge and overall professionalism of Malcolm’s team, and particularly their conscientiousness in coordinating efforts with US outside counsel to ensure alignment of our strategy and arguments on a global basis.
I have been involved with a number of IP firms in the US, EU, and other countries. I would, without hesitation, place Malcolm and his firm in the very top tier of lawyers I have worked with.
September 25, 2013; Kai was Malcolm’s client at Malcolm’s previous firm
Kai Larson, US Attorney and Chief Operating Officer, Signpath Pharma; formerly Associate General Counsel, Sun Products Corporation September 25, 2013